Armata Pharmaceuticals Price Target Maintained With a $7.00/Share by HC Wainwright & Co.

Armata Pharmaceuticals Price Target Maintained With a $7.00/Share by HC Wainwright & Co.

Dow JonesMay 8 21:45

HC Wainwright & Co. Reiterates Buy on Armata Pharmaceuticals, Maintains $7 Price Target

HC Wainwright & Co. analyst Joseph Pantginis reiterates Armata Pharmaceuticals (AMEX:ARMP) with a Buy and maintains $7 price target.

BenzingaMay 8 21:35

Analysts Offer Insights on Healthcare Companies: Valneva (VALN), Denali Therapeutics (DNLI) and Armata Pharmaceuticals (ARMP)

TipRanksMay 8 18:50

Armata Pharmaceuticals Q1 2024 Earnings: Narrower Losses and Strategic Advances

Yahoo FinanceMay 8 09:08

Armata Pharmaceuticals Q1 EPS $(0.69) Misses $(0.31) Estimate, Sales $966.00K Miss $1.10M Estimate

Armata Pharmaceuticals (AMEX:ARMP) reported quarterly losses of $(0.69) per share which missed the analyst consensus estimate of $(0.31) by 122.58 percent. This is a 72.5 percent decrease over losses

BenzingaMay 8 04:41

Armata Pharmaceuticals | 10-Q: Quarterly report

SEC announcementMay 8 04:32 · Announcements